Sign in
NTRBW Stock Price, Chart, Stats & News
Nutriband Inc.
Save
26.04M
Market cap
–
Current P/E
–
Forward P/E
NTRBW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 32.63% |
Operating margin | -406.46% |
Pretax margin | -560.84% |
Net margin | -560.84% |
Effective tax rate | – |
ROA | -151.77% |
ROE | -185.35% |
D/E | 0.03x |
Interest coverage ratio | -442.24x |
NTRBW valuation
P/E | – |
P/S | 20.63x |
P/B | 6.17x |
P/CF | -8.25x |
P/FCF | -8.34x |
P/OCF | -8.25x |
PEG | 0.52x |
EV multiple | -4.16x |
About
Nutriband Inc. is a pharmaceutical company dedicated to advancing a diverse pipeline of transdermal drug products. Foremost among its developmental initiatives is an abuse-deterrent fentanyl transdermal system. This innovative patch aims to provide both healthcare providers and patients with an extended-release fentanyl solution for the effective management of chronic pain.
Similar securities
Based on sector and market capitalization
Report issue